Key players operating in the urea cycle disorder treatment are Charles River, Roche, llumina, and Agilent Technologies, Inc., among others. Charles River is one of the leading players and offers genomic screening services to help identify genetic mutations responsible for urea cycle disorders. The growing diagnosis of Urea Cycle Disorder Treatment Market Size, especially in developing nations,...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian